Marrubiin is the bitter principle of the white horehound (Marrubium vulgare L; fam. Labiatae/ Marrubiae), a plant that grows in dry areas. It also occurs widely in other higher plants.
The structure of this compound was elucidated only in 1953 bz COCKER and al. 1 on the basis of spectroscopic and degradation studies. Though confirmation of the direct chemical synthesis is still lacking, marrubiin has been assigned the formula I, corresponding to a furanoid diterpene. The function of substances of this type in plants is still unknown, and little is known of the mechanism of their formation in plant tissues.
The general scheme of the biosynthesis of natural products with terpenoid and steroid structures is linked with the theory formulated by RUZICKA 2 under the name of the biogenetic law of active isoprene.
Whereas the literature contains a considerable amount of information on the biosynthesis of the animal sterols 3 , it contains much less on the biosynthesis of typical sterols 3 and terpenes 4 of higher plants.
In the preliminary investigation into the mechanism of formation of marrubiin 5 , the incorporation of some simple precursors such as [1-14 C] The choice of mevalonate was based on its importance as a necessary stage in the biosynthesis of terpenes 4 , and the consequent need to check that it is also used in the formation of marrubiin.
The two acetates, labelled on the methyl and on the carboxyl group respectively, were used to verify the fundamental role of active acetate.
The other substances used were pyruvate and anions of bicarboxylic and tricarboxylic acids, chosen from among the most important components of the Krebs cycle.
It seemed important to study the role of the Krebs cycle in the biosynthesis of molecules of plant origin. It leads to the formation of C02 and molecules containing from 3 to 6 carbon atoms. The formed C02 could be utilized in the synthesis of natural products by carboxylation reactions.
Similar investigations have been carried out on a phytosterol 6 and on a long straight-chain paraffin 7 , which are among the principal components of wistaria flowers (Wistaria Sinensis).
Materials and Methods

a) Cultivation of the plant and administration of the labelled compounds
The radioactive compounds were supplied by the Radiochemical Centre at Amersham (UK), and were diluted with a high-purity carrier (Merck).
The white horehound plants (Marrubium vulgare L) were used for these experiments in June and July, i. e. during their flowering period, when the terpene anabolism is most active.
The plants were cut above the roots and incubated at 25 °C with solutions consisting of distilled water, labelled compounds, and adenosine triphosphate (ATP) as a source of energy and of phosphate.
The solution was prepared by dissolution of 100 mg of ATP and the quantity of radioactive compound shown in Table 1 Table I . Possible precursors used in marrubiin biosynthesis.
Each parent solution was divided between 5 containers, in which the stems were immersed, the average overall weight of the plant tissue being 300 g.
The metabolism times were calculated from two hours after administration, since this is the time required for the complete absorption of the solution by the tissue.
50 to 100 ml of distilled water were added roughly every 10 hours.
After the predetermined metabolism time (24, 36, 48, 72 and 96 hours), the plants were dried at 60 °C until all moisture had been eliminated.
b) Extraction and purification of marrubiin
The leaves, flowers, and stems were shredded, pulverized, and extracted for 36 hours with diethyl ether. The dark green ether extract was decolorized with vegetable charcoal, and the colourless liquid, when dried in a rotary evaporator, gave a yellow crystalline residue. The residue was taken up in a little ether and left for a few hours to remove traces of chlorophyll and fats because the marrubiin is much less soluble in ether than the other ones. The process was repeated several times.
The crude marrubiin was crystallized several times from ethyl alcohol until its radioactivity was constant. The yield varied between 200 and 250 mg.
The chemical purity of the product was assessed by means of its melting point (158 -160 °C), and for some samples by infrared spectroscopy and elementary analysis.
The radiochemical purity of each sample was checked by thin-layer chromatography with a 7:3 v/v mixture of ethyl acetate and cyclohexane as the eluent.
c) Degradation of marrubiin
The marrubiin (I) was degraded to the corresponding keto derivative (II) (Fig. 3 ) in order to find the 7 A. BRECCIA and A. ABBONDANZA, Z. Naturforschg. 22 b, 50 [1967] . distribution of the radioactivity between the decahydronaphthalene portion and the furan ring. The degradation was carried out by ozonolysis of the anhydrotetrahydromarrubiin as described in the literature
d) Radioactivity measurements
The radioactivity was measured with a liquid scintillation counter supplied by SELO. The scintillators used were 2,5-diphenyloxazole (PPO) as the primary scintillator and l,4-bis-2 (5-phenyloxazolyl) benzene (POPOP) as the secondary scintillator in toluene solution. The efficiency of the instrument was found to be about 70% in the measurement of standard samples of 14 C hexadecane under the same experimental conditions. Table II . Incorporation data of some precursors in marrubiin at various metabolism times. * The specific incorporation is the ratio between the specific activity of the marrubiin and the specific activity of the precursors. The total incorporation is the ratio between the total activity of the marrubiin and the total activity of the precursors. The maximum incorporation of nearly all the compounds occurred between the 36th and the 48th hour of metabolism, the only exception being mevalonate for which the maximum must have occurred before the 24th hour.
Results and Discussion
After the 48th hour, there is a considerable loss of activity in the marrubiin, with a tendency towards levelling between the 72nd and 96th hour.
It can be seen from the graphs that there is a fairly rapid turnover of marrubiin, from which it can be calculated that the biological half-life is about 24 hours.
The analysis of these curves (apart from that of mevalonate) shows that the early, ascending part of the curve probably corresponds to the following two phenomena: 1. the assimilation of the radioactive compound by mechanical transport processes, enabling it to reach the cell location at which the biosynthesis occurs; and 2. the sequence of metabolic reactions leading to the conversion of the precursor into marrubiin.
Since the precursors used are metabolites similar to one another, the rate of physiological assimilation should show a similar behaviour in every case; consequently, the qualitative differences in the ascending parts of the curves are actually due to the series of reactions leading to the synthesis of the compound.
There may also be competitive reaction sequences, in which the precursor is converted by different metabolic paths into marrubiin.
The descending part of each curve is due to the exhaustion of the radioactive compound and to the dilution of this and of the labelled marrubiin by the corresponding endogenous compounds.
The amount of mevalonate incorporated is much greater tkan that of the other precursors, owing to its acknowledged specificity in the biosynthesis of terpenoid substances. The specificity of mevalonate and its biogenetic proximity to marrubiin are shown by its rapid utilization by the organism for the formation of the terpene.
It is certain that all or nearly all of the mevalonate was consumed during the first 24 hours after administration, and that after the 24th hour, owing to the rapid biological exchange, the activity of the marrubiin decreases and tends towards a fairly constant value between the 72nd and 96th hour.
The relatively high incorporation of mevalonate provides further confirmation of the terpenoid structure of marrubiin.
The course of incorporation of the two acetates, labelled on the methyl and on the carboxyl group respectively, is roughly similar, with a maximum around the 36th hour of metabolism. The activity of the marrubiin is lower and the incorporation is slower than in the case of mevalonate, since after undergoing the condensation to form acetoacetyl coenzyme A, it is converted by a complex route into /?-hydroxymethyl-glutaryl coenzyme A, and thence into mevalonate. The incorporations of the two acetates confirm that the formation of the terpen occurs via mevalonate for condensation head by tail and partial decarboxylation. Also the slight differences in the uptake of the two acetates are in agreement with the oversaid pathway.
Pyruvate also exhibits good incorporation. Though this compound enters into various metabolic cycles, it may be assumed that it undergoes oxidative decarboxylation to active acetate.
Analysis of the behaviour of the succinate, ketoglutarate and citrate, bearing in mind the Krebs cycle, leads to the following general conclusions:
The succinate may be converted into acetyl CoA, and thence by the usual route into the terpene. Before conversion into acetyl CoA, the succinate must be oxidized to oxalacetate (Krebs cycle), and the subsequent transformation follows two paths. In the first, it undergoes double decarboxylation outside the cycle itself. In this case, however, the marrubiin biosynthesized from [1,4-14 C] succinate should not be active, whereas activity, though only slight, is actually observed. The second route follows the cycle as far as citrate, and the reverse reaction of this symmetrical molecule can lead to the formation of oxalsuccinate and labelled acetyl CoA.
[2,3-14 C] succinate is converted by these two routes into acetyl CoA without loss of its two radioactive atoms. The kinetic of the incorporation of this compound into marrubiin is similar to those of acetates and pyruvate, though the amount incorporated is smaller.
[5-14 C] ketoglutarate and [1,5-14 C] citrate are utilized in the Krebs cycle in the same manner as [1, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C] succinate. In fact, the specific activity of the marrubiin biosynthesized from these three compounds is of the same order however, insignificant.
In other experiments we have tested the incorporation also of H 14 C03 e in marrubiin but it was very low. The specific incorporation was 0.061 -10 -4 and 0.091-10" 4 and the total incorporation 0.091-10~4 and 0.136-10~4 respectively at the 24th and 48th hour of metabolism. In this case the order of incorporation was smaller by a factor of about 10 than in the experiments with [1, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Table III . Distribution of 14 C in marrubiin (I) and in ketolactone (II). * a = specific activity.
of carbon is of the same order in the marrubiin and in the degradation products, demonstrating (at least for the precursors used by us) the common biogenetic origin of the side chain attached to C6, including the furan system, and of the decahydronaphthalene system.
The distribution of radioactivity between the decahydronaphthalenic and furanic parts is in good agreement with the suggestion that all the metabolites, with the exception of mevalonate, are degraded to acetate through the Krebs cycle before their utilization.
In Fig. 3 it is shown the localization of the 14 C atoms in the marrubiin (I) derived from the various precursors and in ketolactone (II). These schemes are delined conforming to the terpenoid structure of marrubiin. The found values of radioactivity remained in decahydronaphthalenic part agree with the calculated ones.
It seems from these results that marrubiin cannot be obtained with a high specific activity and in high radiochemical yields by the administration of pre-
